| # | Drug | Count |
|---|---|---|
| 0 | ROSUVASTATIN | 64 |
| 1 | ASPIRIN | 40 |
| 2 | ASPIRIN 325 MG | 40 |
| 3 | ASPIRIN 81 MG | 40 |
| 4 | OLANZAPINE | 37 |
| 5 | UPADACITINIB | 35 |
| 6 | PEMBROLIZUMAB | 33 |
| 7 | EZETIMIBE | 31 |
| 8 | ACETAMINOPHEN | 28 |
| 9 | INCLISIRAN | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONASEMNOGENE ABEPARVOVEC-BRVE | 1 | 0.0833 |
| 1 | DELANDISTROGENE MOXEPARVOVEC-ROKL | 12 | 0.0326 |
| 2 | LIPFENDRA | 1 | 0.0244 |
| 3 | NATURAL VEGETABLE LAXATIVE | 1 | 0.0244 |
| 4 | SUNVOZERTINIB | 1 | 0.0244 |
| 5 | AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE | 26 | 0.0231 |
| 6 | ALVIMOPAN | 1 | 0.0217 |
| 7 | VIMSELTINIB | 7 | 0.0128 |
| 8 | FLURAZEPAM HYDROCHLORIDE | 5 | 0.0123 |
| 9 | SELUMETINIB | 16 | 0.0095 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 77 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 60 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 59 |
| 3 | Kinase Inhibitor [EPC] | 58 |
| 4 | Corticosteroid [EPC] | 51 |
| 5 | Janus Kinase Inhibitor [EPC] | 40 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 40 |
| 7 | Benzodiazepine [EPC] | 32 |
| 8 | Dietary Cholesterol Absorption Inhibitor [EPC] | 31 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 5 | 0.0056 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 2 | 0.0033 |
| 3 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 4 | Lipopeptide Antibacterial [EPC] | 25 | 0.0026 |
| 5 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 6 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 7 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 8 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 2 | 0.0010 |
| 9 | Thyroid Hormone Receptor beta Agonist [EPC] | 2 | 0.0009 |